{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:38:42Z","timestamp":1781239122858,"version":"3.54.1"},"reference-count":40,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:00:00Z","timestamp":1465776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100009431","name":"Baxalta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The bleeding propensity in von Willebrand disease (<jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content>) is usually moderate or mild and patients with <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content> do not need continuous treatment, but do require extra increased haemostatic cover when undergoing dental or surgical procedures. Desmopressin can be effective in certain patient groups and this has been considered in a previous publication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>This paper now seeks to evaluate current knowledge and practice in the use of factor concentrate in the management of <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content> patients undergoing invasive procedures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A literature search was performed on the use of factor concentrates to cover invasive procedures and a survey of current practice in a number of specialist haematology centres across Europe represented by the European Haemophilia Strategy Board was conducted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our review of the literature and the results of the survey showed considerable heterogeneity in treatment regimens, and a lack of consistency in reporting of the variables that determine factor concentrate dosing and monitoring.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>By analysing the literature, examining guidelines and using consensus deliberation, this survey allowed the group to develop recommendations for management of <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content> patients undergoing invasive procedures.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hae.12955","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T10:27:09Z","timestamp":1465813629000},"page":"739-751","source":"Crossref","is-referenced-by-count":18,"title":["Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey"],"prefix":"10.1111","volume":"22","author":[{"given":"J.","family":"Windyga","sequence":"first","affiliation":[{"name":"Department of Disorders of Hemostasis and Internal Medicine Institute of Hematology and Transfusion Medicine Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Dolan","sequence":"additional","affiliation":[{"name":"Haemophilia Unit St Thomas\u2019 Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Altisent","sequence":"additional","affiliation":[{"name":"Servicio de Hematologia \u2013 Unidad de Hemofilia Hospital Vall D'Hebron Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Katsarou","sequence":"additional","affiliation":[{"name":"Thrombosis and Haemostasis Unit Laikon General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u2010F.","family":"L\u00f3pez Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Servicio Hematologia Complexo, Hospitalario A Coru\u00f1a INIBIC La Coru\u00f1a Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Z\u00fclfikar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology Cerrahpasa Faculty of Medicine Istanbul University Cerrahpasa Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the EHTSB","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040403"},{"key":"e_1_2_8_3_1","first-page":"107","article-title":"Vasopressin\u2010induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP","volume":"106","author":"Kaufmann JE","year":"2000","journal-title":"Blood"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12763"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02588.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12005"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02534.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11124"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1612977"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02445.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01430.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02206.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00688.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01570.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-10-0631"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12237"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12496"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12497"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-27822"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.2.450"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02562.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12258"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830300305"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029606296399"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01643.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13064"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-153296"},{"key":"e_1_2_8_28_1","first-page":"117","article-title":"Federici AB on behalf of AICE (Italian Association of Haemophilia Centres) Evidence\u2010based recommendations on the treatment of von Willebrand disease in Italy","volume":"7","author":"Mannucci PM","year":"2009","journal-title":"Blood Transfus"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/7.4.245"},{"key":"e_1_2_8_30_1","first-page":"1261","article-title":"Diagnosis and management of Von Willebrand disease: guidelines for primary care","volume":"80","author":"Yawn BP","year":"2009","journal-title":"Am Fam Physician"},{"issue":"3","key":"e_1_2_8_31_1","first-page":"2","article-title":"Treatment of von Willebrand disease in Spain consensus document","volume":"97","author":"Batlle J","year":"2012","journal-title":"Haematologica"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-922230"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613227"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008173430702"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12498"},{"key":"e_1_2_8_36_1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1160\/TH05-01-0013","article-title":"Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada \u2013 is it necessary to define a new upper reference range for factor VIII?","volume":"93","author":"Wells PS","year":"2005","journal-title":"Thromb Haemost"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90166-3"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613747"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12185"},{"key":"e_1_2_8_40_1","unstructured":"Evidence levels and grades of evidence. GRADE. Available athttp:\/\/www.bcshguidelines.com\/BCSH_PROCESS\/EVIDENCE_LEVELS_AND_GRADES_OF_RECOMMENDATION\/43_GRADE.html. Last Accessed April 11 2016."},{"key":"e_1_2_8_41_1","unstructured":"Guidelines of the Nordic Hemophilia Council.Nordic guidelines for diagnosis and management of von Willebrand disease.http:\/\/www.nordhemophilia.org\/library\/Files\/PDF-skjol\/NordicGuidelinesVWD_SL23APR2008b.pdfLast Accessed April 11 2016."}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhae.12955","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.12955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T23:27:58Z","timestamp":1694906878000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.12955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1111\/hae.12955"],"URL":"https:\/\/doi.org\/10.1111\/hae.12955","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]}}}